SUMMARY Aspirin and paracetamol consumption have been compared in 346 matched pairs of patients with haematemesis and melaena, and control individuals in the general community. Both aspirin and paracetamol intake were more common in patients than in controls, but the association for aspirin was stronger and was apparent with both recent and habitual intake, whereas for paracetamol the association was not detectable for habitual intake. The 
Previous studies have consistently demonstrated an association between recent aspirin intake and major upper gastrointestinal haemorrhage, but the strength and significance of this relationship have been contested.' The evidence is derived exclusively from retrospective case-control investigations, in all of which the choice of controls can be criticised. In particular all studies to date have used hospital patients as controls, whereas a control group taken from the community would seem more appropriate, as most patients admitted with haematemesis and melaena are presenting to hospital for the first time. Furthermore, the existence of an association between salicylates and haemorrhage does not necessarily imply that salicylates cause haemorrhage. It is possible that a proportion of patients who bleed take aspirin to relieve indigestion or other symptoms associated with the onset of their haemorrhage. If this is so, a similar association should be found for other analgesics such as paracetamol which are not thought to cause bleeding. We have therefore compared the recent drug exposure of patients suffering from acute upper gastrointestinal haemorrhage with that of community controls, looking particularly for any differences between aspirin and paracetamol. Received for publication 21 Most of these were housewives.
The numbers of patients and controls taking corticosteroids were identical, but twice as many patients as controls were using non-steroidal antiinflammatory drugs (NSAI) ( Table 2 ). All pairs in which either the patient or his control were taking steroids, NSAI, or warfarin were excluded from further analysis, leaving a total of 277 matched pairs in which we compared exposure to aspirin and paracetamol. Aspirin consumption was independent of paracetamol intake in both cases and controls, allowing us to examine the relationship of each drug to bleeding independently. Both drugs were used more often by the haematemesis group than by controls (Table 3 ), but the association of paracetamol with bleeding disappeared when only long-term use of the drug was considered (Table 4) . While the association between aspirin and bleeding also decreased for longer periods of exposure, it remained discernible, and, for each of the periods of exposure which we considered, the association of aspirin with bleeding (in terms of relative risk) was approximately twice that of paracetamol.
Examination of relative risks in heavy and light users of analgesics showed that the highest risk ratio (16.0) obtained in heavy aspirin users (more than 20 tablets in the past week): by contrast in heavy paracetamol users the risk ratio was 2.4, little more than the overall ratio. Table 5 gives the indications for which subjects took analgesics. More patients than controls took paracetamol for indigestion, but not for headache or upper respiratory tract infections, and for arthritis the difference was small. In contrast, aspirin was used more often by patients than controls for all indications, although again the difference was most marked among those taking the drug for dyspepsia. Table 6 shows the risk ratios for aspirin and paracetamol consumption in bleeding patients relative to their controls, subdivided according to the lesions found in the bleeding patients. The risk ratios were high in all comparisons for aspirin; they were also raised for paracetamol consumption in individuals with duodenal ulcer and in the miscellaneous group that was left when all those with chronic or acute ulcers or who had unequivocally normal findings were removed. By comparing the risk ratios for aspirin and paracetamol in each diagnostic group it was possible to estimate the degree of extra association present for aspirin. This was greatest for duodenal ulcer, followed by gastric ulcer, and then erosions, or no lesion found, with no excess of risk ratio for the miscellaneous group.
The excess of heavy alcohol drinkers noted in the patients was small, 56/346 (16%) in the cases and 33/346 (10%) in the controls. Examination by the matched pairs technique showed that in neither patients nor controls was there any association between heavy drinking and aspirin consumption (Table 7) . 
Discussion
Our study differs in two important respects from earlier investigations. We chose a community-based control group as being more directly comparable with the patients with haematemesis and melaena. This may initially appear perverse, but we found, in fact, that two-thirds of our patients with bleeding had never attended hospital with dyspepsia. For these a community control was plainly appropriate. The remaining third had attended, but so had one-sixth of the control group, so that in the event there was overall equivalence for five out of six of the patients and controls, much closer than if a hospital control had been used. Furthermore, the use of hospital controls has been found to introduce significant biases in case-control studies.3
Secondly, our choice of paracetamol as a reference drug for comparison has allowed us to measure the extent to which analgesic intake may be consequential upon the presence of a bleeding lesion and the extent to which it may be the cause of bleeding, the key assumptions being that paracetamol does not induce bleeding itself and is used for parallel indications to aspirin.
That patients were interrogated in hospital while controls were questioned at home was a potential source of error; but any bias which might have arisen because the interviews were not 'blind' or because of differences between the recall of individuals in the two different situations should have applied equally to aspirin and paracetamol, and should not have affected comparisons between the two.
The excess use of NSAI by haematemesis patients may simply reflect a reluctance to prescribe these drugs on the part of doctors in the two practices from which our controls were drawn. It seems more likely, however, that it represents a genuine association between NSAI and upper gastrointestinal haemorrhage. Such an association has often been suggested but is supported, outside this study, only by anecdotal evidence, and it deserves further investigation. By contrast, the equivalence of corticosteroid intake in our cases and controls suggests that little, if any, risk attaches to the use of corticosteroid drugs in ordinary small clinical doses.
The correlation which we have demonstrated between paracetamol and bleeding has not been described before and was probably not causal. It applied to recent intake but not to long-term exposure, and such a pattern is to be expected if patients took paracetamol for symptoms associated with bleeding or with the presence of a lesion which was already destined to bleed. This suggestion is supported by consideration of the indications for which patients took paracetamol; thus, seven patients but only one control took paracetamol to control indigestion and these were short-term takers of paracetamol. In addition one other patient took paracetamol for chest pain which was probably indigestion associated with a hiatal hernia, and two in the latter part of the survey, when a specific question was asked which had not before been included, said the indications were feelings of dizziness and malaise. By contrast, patients and controls matched exactly in numbers when the indications were headache and colds or influenza. There was a modest excess of paracetamol intake in patients with arthritis compared with controls, but it seemed likely that several of these had been previous takers of NSAI. For each of the time periods of analgesic exposure which we examined the association of aspirin intake with bleeding was stronger than that for paracetamol. Our evidence therefore suggests that highly buffered aspirin preparations are no more dangerous than paracetamol, a conclusion which is in harmony with experimental evidence.
In contrast, the association between bleeding and non-buffered aspirin taken for indigestion (13 takers in the patients and none in the controls) was stronger than for paracetamol and therefore argues for a causal association with bleeding.
'It has been proposed that the risk of bleeding due to aspirin is particularly high in patients with upper respiratory tract infections5 or when the drug is taken with alcohol,6 but we found no evidence to support either of these suggestions. Others have, in general, found the association between aspirin intake and bleeding to be strongest in patients who had nonchronic ulcer bleeding. By using the results for paracetamol in Table 6 to make allowance for analgesic intake associated with, rather than causal of, the bleeding lesion, the strongest association in our data is for chronic duodenal ulcer followed by gastric ulcer and then the acute lesion and no lesion group. It would be unwise, however, to place reliance upon precise calculations using the individual pairs of risk ratios. The results suggest an association for all three diagnostic groups; they are not strong enough to say that particular patients are at special risk of aspirin damage.
The final proof that aspirin can cause haematemesis and melaena can only come from randomised controlled trials, such as current investigations into the use of aspirin in the prevention of strokes and heart attacks. In the meantime, our results allow us to predict the risk of bleeding which is likely to be associated with aspirin once allowance has been made for any excess of aspirin intake by patients with haematemesis and melaena that is a consequence of their bleeding lesion and is not a cause of it.
We suggest that, of the overall aspirin consumption by a group of patients with haematemesis and melaena, about one-third can be accounted for by the amount ordinarily consumed in a control population, and another third can be attributed, by reference to the paracetamol excess, to intake which is consequential upon the presence of the bleeding lesion, but is not causal of bleeding. The remaining third is unaccounted for and could be causal of bleeding.
The actual chances of bleeding in an individual taking aspirin cannot be calculated directly from a retrospective controlled study such as ours, because the cases analysed have not been drawn from a defined population, and because there is at least one other hospital serving the local population to which cases might be taken. Assuming, however, that the analgesic habits of our controls are representative of the general population, the risk ratios in Table 4 can be used to obtain an estimate of the relative risk involved in aspirin intake. The use of these ratios has a particular advantage in that the paracetamol figures allow us to take account of drug intake which is consequential upon the presence of a lesion that is already destined to bleed. As the ratios for all time periods are about twice as high for aspirin as for paracetamol, they suggest a doubling of risk for aspirin intake. There are some 300 admissions with acute upper gastrointestinal bleeding in Nottingham each year and these are drawn from a population of 700 000 people, so that the overall chances of bleeding irrespective of the nature of any causative factors are between 40 and 50 per 100 000 population per year. Again, assuming that the analgesic consumption of our controls is typical of the general population, this would imply for a regular user of aspirin an attributable risk of 35 to 45 hospital admissions per 100 000 regular users per year. Given the uncertainties involved in such calculations, this figure is compatible with Levy's estimate7 of 15 per 100 000 regular users per year.
Our results differ from those of Levy, however, because they suggest that some risk attaches to shortterm use. If this is still a doubling, then for the occasional user this would be of the order of one episode for every quarter million courses of treatment.
